Abstract Details
|
In Hye Jeong, MD
(National Cancer Center)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jae Won Hyun, MD | No disclosure on file |
| No disclosure on file | |
| Ho Jin Kim, MD (National Cancer Center) | Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology. |